Clinical trial
Study of the Effect of SR57667B on the Progression of Symptoms in Patients With…
NCT00228150 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00228150 |
|---|---|
| Title | Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease |
| Official title | A Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy, Safety and Tolerability Study of SR57667B in Outpatients With Early Parkinson's Disease |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | SR57667B |
| Enrollment | 564 |
| Start date | Jul 1, 2003 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 28, 2005 |
| Last update posted | Dec 23, 2008 |
| Countries | Austria, Canada, Denmark, France, Germany, Morocco, Netherlands, Portugal, South Africa, Spain, Sweden, Tunisia and 1 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: